Description

NOBIVAC® Feline 1-HCP has been shown to be effective for vaccination of healthy cats 9 weeks of age or older against feline rhinotracheitis, calici, and panleukopenia viruses.
-A quality core vaccine shown to be effective for vaccination of healthy cats 9 weeks of age or older against feline rhinotracheitis, calici, and panleukopenia viruses.

Benefits

Effective against the most common threatening viral infections—calicivirus, herpesvirus, and the deadly feline parvovirus, panleukopenia
NOBIVAC® Feline 1-HCP has been shown to block the replication of canine parvovirus (CPV) in cats1
Evidence shows that CPV-2a, CPV-2b, and CPV-2c isolates can replicate in cats, producing clinical signs of feline panleukopenia62-63
Non-adjuvanted formula
Optimal choice for healthy indoor cats

Dosage and Administration

Transfer the contents of the diluent vial to the Nobivac^®: Feline 1-HCP vial aseptically. Use entire contents immediately after rehydration.

Inject one dose (1 mL) subcutaneously or intramuscularly at 9 weeks of age or older and repeat with a second dose 3 to 4 weeks later.

WARNINGS:

• Contains gentamicin as a preservative.
• Some reports suggest that in cats, the administration of certain veterinary biologicals may induce the development of injection-site fibrosarcomas.
• Do not vaccinate pregnant cats.
• The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.

Nobivac Feline - 1-HCP is a registered trademark of Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc.

Click here for our Vaccine Shipping Schedule.